Sherbrooke Park Advisers LLC Adma Biologics, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 13,949 shares of ADMA stock, worth $250,663. This represents 0.06% of its overall portfolio holdings.
Number of Shares
13,949
Previous 12,269
13.69%
Holding current value
$250,663
Previous $137 Million
103.29%
% of portfolio
0.06%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$335 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$326 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$234 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$227 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$155 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.53B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...